Grant Amount$375,000 USD
Grant Term3 Years
Start of Grant TermJuly 1, 2027
Letter of Intent DeadlineDecember 15, 2026 1:00 PM (ET)
Letter of Intent Notification DateFebruary 2027
Application DeadlineApril 1, 2027 1:00 PM (ET)
Decision DateJune 2027
Description
The Breast Cancer Research Foundation-AACR Career Development Awards represent a joint effort to support early-career investigators to conduct basic, translational, clinical, or population-based research with direct applicability and relevance to breast cancer.
The grants provide $375,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborator, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses.
Citizenship Requirements
There are no citizenship or geographic requirements. However, by submitting an application for this grant, an applicant applying from an institution located in a country in which they are not a citizen, or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.
| Predictor | Importance | Explanation |
|---|---|---|
| Scientific significance | Very High | Addresses an important cancer-related problem or an unmet research need. |
| Innovation and originality | Very High | Introduces novel hypotheses, methods, technologies, or treatment strategies. |
| Research methodology | Very High | Presents rigorous study design, appropriate methods, measurable outcomes, and sound analysis. |
| Preliminary research evidence | High | Provides supporting data demonstrating the scientific rationale and feasibility of the project. |
| Investigator track record | High | Demonstrates relevant publications, research experience, productivity, and expertise. |
| Translational potential | High | Shows potential to move discoveries toward improved cancer prevention, diagnosis, or treatment. |
| Clinical and patient impact | High | Explains how the research could improve patient outcomes or cancer care. |
| Project feasibility | High | Includes realistic timelines, resources, recruitment plans, and achievable objectives. |
| Institutional research environment | Medium–High | Demonstrates access to suitable laboratories, facilities, clinical resources, and collaborators. |
| Career development and mentorship | High for fellowships | Shows strong mentorship, training objectives, and potential for career progression and research independence. |
| Collaboration and interdisciplinary expertise | Medium–High | Brings together complementary expertise, particularly for complex translational or team-science projects. |
| Alignment with specific grant program | Very High | Matches the cancer type, research topic, applicant career stage, and eligibility requirements of the particular AACR funding opportunity. |
These predictors are based on AACR's stated funding priorities and published program information. They are not a statistical ranking of factors proven to cause grant success.
AACR+2
2. Major AACR funding programs
| Grant category | Examples |
|---|---|
| Research fellowships | AACR Basic Cancer Research Fellowship; Hematologic Malignancies Research Fellowship |
| Career development awards | AACR-Lustgarten Foundation Career Development Awards |
| Independent research grants | AACR Innovation and Discovery Grants; Trailblazer Cancer Research Grants |
| Translational research | AACR grants supporting new cancer treatments and clinical applications |
| Team science grants | Stand Up To Cancer (SU2C) Team Grants |
| Specialized cancer grants | Breast, pancreatic, lung, bladder, kidney, sarcoma, and other cancer-specific programs |
AACR+2
3. Historical funding information
Total funding awarded: More than $551 million.
Researchers supported: More than 3,500.
Funding history: Since 1993.
Overall grant success rate: Not publicly established in the sources reviewed. The total number of funded researchers cannot be used to calculate an application success rate without the total number of applications received.
AACR+1
4. Current funding opportunities
AACR's current funding page lists opportunities with deadlines extending into 2027. Examples include:
AACR-QuadW Foundation Sarcoma Research Fellowship — $60,000.
Bosarge Family Foundation-Waun Ki Hong Scholar Award — $120,000.
AACR-Lustgarten Foundation Career Development Award — $300,000.
AACR John and Elizabeth Leonard Basic Cancer Research Fellowship — $130,000.
These are individual program awards, and eligibility and deadlines differ.
At the start of the grant term (July 1, 2027), applicants must:
At the start of the grant term (July 1, 2027), applicants cannot:
Sponsor Institute/Organizations: American Association for Cancer Research
Sponsor Type: Corporate/Non-Profit
Address: 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 15, 2026
Apr 01, 2027
$375,000
Affiliation: American Association for Cancer Research
Address: 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404 USA
Website URL: https://www.aacr.org/grants/breast-cancer-research-foundation-aacr-career-development-awards/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.